While TGFβ can thus initially act as a tumor suppressor [13], in later disease stages tumor cells become increasingly resistant to the cytostatic effects of TGFβ, and it can in contrast even function as a tumor promoter. The gene discussed is TGFB1; the disease is neoplasm.